BRAIN Unit is working towards becoming a UK centre of excellence for delivering novel cell, drug and growth factor therapies to patients with currently untreatable neurological and neurodegenerative diseases.
This includes conditions such as:
- Huntington’s disease
- Parkinson’s disease and
- multiple sclerosis.
We believe that through research, innovation and collaboration, we can help deliver new ways to treat these illnesses and improve life for those affected.
Building on Welsh expertise
BRAIN Unit is based in the Welsh capital of Cardiff, and is composed of researchers from three of Wales’ leading universities – Cardiff University, Swansea University and Bangor University. It is funded by Welsh Government through Health and Care Research Wales.
Wales has particular strengths in basic neuroscience, experimental medicine research, stem cell transplantation and brain imaging. As a result, it has attracted considerable industrial investment from the regenerative medicine and medical devices industries.
The BRAIN Unit will exploit this expertise and resource to bridge a crucial gap at the neurosurgical NHS trials support interface. It will support pre-clinical laboratory and imaging validation, first-in-man clinical trials and driving novel therapies onward into clinical practice.
Through innovation and collaboration, BRAIN Unit aims to:
- Develop new and refine existing systems for delivery of therapeutics into the human brain.
- Develop the appropriate infrastructure for capturing relevant high-quality patient data to measure real clinical and social impact, as well as continuing to support ongoing mechanistic translational research.
- Build a clinical and health economic outcome, social care and service delivery research portfolio.